Deerfield Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.6M | Buy |
5,115,953
+1,011,996
| +25% | +$18.3M | 1.68% | 18 |
|
|
2025
Q1 | $84M | Sell |
4,103,957
-210,383
| -5% | -$4.31M | 1.66% | 19 |
|
|
2024
Q4 | $111M | Buy |
4,314,340
+3,412,590
| +378% | +$87.7M | 2.1% | 13 |
|
|
2024
Q3 | $15M | Buy |
901,750
+32,500
| +4% | +$540K | 0.22% | 59 |
|
|
2024
Q2 | $16.7M | Buy |
869,250
+202,250
| +30% | +$3.89M | 0.28% | 54 |
|
|
2024
Q1 | $15.8M | Buy |
+667,000
| New | +$15.8M | 0.27% | 60 |
|
|
2023
Q3 | – | Sell |
-2,535,723
| Closed | -$30.1M | – | 100 |
|
|
2023
Q2 | $30.1M | Hold |
2,535,723
| – | – | 0.64% | 38 |
|
|
2023
Q1 | $33.6M | Buy |
2,535,723
+55,524
| +2% | +$736K | 0.75% | 38 |
|
|
2022
Q4 | $27M | Buy |
+2,480,199
| New | +$27M | 0.56% | 51 |
|